Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics
The Australian oyster’s semi-purified hemolymph protein extract (HPE) has shown antimicrobial-biofilm inhibitory activity against various strains of Streptococcus pneumoniae and Streptococcus pyogenes. HPE improved the effectiveness of conventional antibiotics by 2 to 32-fold. The study also found that HPE was non-toxic to human lung cells up to 205 μg/mL, demonstrating safety above effective concentrations. This finding provides opportunities for pharmaceutical and aquaculture industry development, highlighting the specificity and high capacity of antimicrobial proteins and peptides.
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!